Abstract: Zheng Guo Biomedical Index is an index composed of Shanghai and Shenzhen 300 Index and China Securities Medicine Index, which reflects the overall performance of China Biomedical Industry. Due to the scale and complexity of the pharmaceutical industry in China, the CSI Biomedical Index can better reflect the development trend of the industry and provide investors with more valuable information.

Text:

1. CSI Biomedical Index is an index launched by China Securities Depository and Clearing Co., Ltd. (CSI Depository and Clearing Co., Ltd.), which is based on the CSI 300 Index and CSI Pharmaceutical Index and reflects the overall performance of China's biomedical industry.

2. The National Biomedical Index is a more refined index, including hundreds of listed companies in the domestic biomedical industry, which can better reflect the development trend of the industry.

3. The CSI Biomedical Index is released monthly by China Securities Depository and Clearing Co., Ltd.. Investors can learn about the development of biomedical industry in China and make investment decisions through this index.

4. The release of national biomedical index can not only reflect the development trend of China's biomedical industry, but also provide investors with more valuable information, so as to better grasp investment opportunities.

Biomedical index is an important investment index, which can help investors to better grasp investment opportunities. Investors can adjust their investment portfolio in time according to the changes of the index to get a better return on investment.

6. The National Biomedical Index is an important indicator reflecting the development trend of China's biomedical industry in real time, which can provide investors with valuable information and help them better grasp investment opportunities, so as to obtain a better return on investment.